SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 01, 17:00
859.90
45.8 (5.63%)
VOLUME 308,222
LIVE
NSE
Apr 01, 17:00
859.80
45.8 (5.63%)
VOLUME 5,415,702
Management Interviews on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
No plan to merge SPARC with Sun Pharma: Dilip Shanghvi 

7.18 pm | 25 Mar 2015 |  Source: CNBC-TV18

With Sun Pharma-Ranbaxy merger complete, Sun is now India's largest and the world's fifth largest drug maker with combined revenue of USD 5.14 billion...

See Rs 400cr increase in top line over next few yrs: Hetero 

3.29 pm | 24 Mar 2015 |  Source: CNBC-TV18

The company has 20 facilities across the globe with portfolio of more than 200 products in 138 countries....

Sun Pharma maintains 13-15% FY15 topline guidance: CFO 

2.54 pm | 18 Feb 2015 |  Source: CNBC-TV18

The company has grown faster than the market in India and would be focused on research and development (R&D) spends going forward, said Uday Baldota, ...

Merger with Ranbaxy might get delayed: Sun CFO Baldota 

11.59 am | 14 Nov 2014 |  Source: CNBC-TV18

The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally....

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.